Exercise alleviates CUS-induced depressive-like behaviors by modulating paracellular and transcellular permeability of the blood-brain barrier in the prefrontal cortex
Behavioural Brain Research · 2025
DOI: 10.1016/j.bbr.2024.115286 ↗Kurz gefasst
Fachartikel in der Zeitschrift Behavioural Brain Research, 2025. Verfasst von Ye Luo und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of fine arts, China West Normal University, Nanchong, China. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Mice, Inbred C57BL, Prefrontal Cortex, Physical Conditioning, Animal. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Bureau of Science and Technology Nanchong City.
Abstract (Originalsprache)
BACKGROUND: Increased blood-brain barrier (BBB) permeability is implicated in the pathophysiology of major depressive disorder (MDD). While aerobic exercise has shown promise in mitigating MDD symptoms by potentially preserving BBB integrity, the detailed mechanisms remain unclear. This study explores these mechanisms to assess aerobic exercise's therapeutic potential for MDD. METHODS: Male C57BL/6 J mice were used in this study to investigate the effects of aerobic exercise on CUS-induced BBB permeability and depressive-like behaviors. Chronic unpredictable stress (CUS)-induced MDD mouse models were divided into three groups: Control, CUS, and CUS+Exercise. We monitored body weight, blood S100β levels, and cytokines via ELISA. Claudin-5 and Caveolin-1 (CAV-1) expressions in the medial prefrontal cortex were evaluated using Western blotting and immunofluorescence. BBB permeability was assessed using biocytin-TMR and Alb-Alexa 594 tracers. Transmission electron microscopy was used to observe ultrastructural changes in the BBB directly. Depression-related behaviors were tested through several behavioral assays. RESULTS: CUS significantly increased CAV-1 expression and Alb-Alexa 594 leakage, suggesting enhanced transcellular BBB permeability. Despite unchanged Claudin-5 levels, its tight junction ultrastructure was altered, leading to increased biocytin-TMR leakage. Aerobic exercise ameliorated these disruptions, reduced inflammatory cytokines, and improved behavioral outcomes in CUS mice. CONCLUSION: Disruptions in both paracellular and transcellular BBB pathways are pivotal in depression development. Aerobic exercise offers potential therapeutic benefits for MDD linked with BBB dysfunction by mitigating stress-induced structural and functional changes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of fine arts, China West Normal University, Nanchong, China.
- College of Physical Education, China West Normal University, Nanchong, China.
- Department of Neurosurgery, Nanchong Central Hospital, The Second Clinical Medical College of North Sichuan Medical College, Nanchong, China.
- Department of Neurosurgery, Nanchong Central Hospital, The Second Clinical Medical College of North Sichuan Medical College, Nanchong, China. Electronic address: 1013791298@qq.com.
Förderung
- Bureau of Science and Technology Nanchong City
Zitieren
APA
Luo, Y., Meng, D., Tang, H., Wu, P., & Zhang, Y. (2025). Exercise alleviates CUS-induced depressive-like behaviors by modulating paracellular and transcellular permeability of the blood-brain barrier in the prefrontal cortex. Behavioural Brain Research. https://doi.org/10.1016/j.bbr.2024.115286
Vancouver
Luo Y, Meng D, Tang H, Wu P, Zhang Y. Exercise alleviates CUS-induced depressive-like behaviors by modulating paracellular and transcellular permeability of the blood-brain barrier in the prefrontal cortex. Behavioural Brain Research. 2025. doi:10.1016/j.bbr.2024.115286
BibTeX
@article{Luo2025,
author = {Luo, Ye and Meng, Dewang and Tang, Hui and Wu, Panwen and Zhang, Yuan},
title = {Exercise alleviates CUS-induced depressive-like behaviors by modulating paracellular and transcellular permeability of the blood-brain barrier in the prefrontal cortex},
journal = {Behavioural Brain Research},
year = {2025},
doi = {10.1016/j.bbr.2024.115286}
}
EUVIMED